- Home
- EPSM vs AVTE Comparison
EPSM vs AVTE Comparison
Compare EPSM & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSM
- AVTE
- Stock Information
- Founded
- EPSM 2010
- AVTE 2018
- Country
- EPSM China
- AVTE United States
- Employees
- EPSM N/A
- AVTE N/A
- Industry
- EPSM
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- EPSM
- AVTE Health Care
- Exchange
- EPSM Nasdaq
- AVTE Nasdaq
- Market Cap
- EPSM 71.3M
- AVTE 72.5M
- IPO Year
- EPSM 2025
- AVTE 2021
- Fundamental
- Price
- EPSM $4.95
- AVTE $2.52
- Analyst Decision
- EPSM
- AVTE Hold
- Analyst Count
- EPSM 0
- AVTE 7
- Target Price
- EPSM N/A
- AVTE $11.75
- AVG Volume (30 Days)
- EPSM 577.3K
- AVTE 61.1K
- Earning Date
- EPSM 01-01-0001
- AVTE 03-27-2025
- Dividend Yield
- EPSM N/A
- AVTE N/A
- EPS Growth
- EPSM N/A
- AVTE N/A
- EPS
- EPSM 0.05
- AVTE N/A
- Revenue
- EPSM $17,906,283.00
- AVTE N/A
- Revenue This Year
- EPSM N/A
- AVTE N/A
- Revenue Next Year
- EPSM N/A
- AVTE N/A
- P/E Ratio
- EPSM $94.28
- AVTE N/A
- Revenue Growth
- EPSM N/A
- AVTE N/A
- 52 Week Low
- EPSM $4.23
- AVTE $1.25
- 52 Week High
- EPSM $6.34
- AVTE $30.29
- Technical
- Relative Strength Index (RSI)
- EPSM N/A
- AVTE 53.59
- Support Level
- EPSM N/A
- AVTE $2.45
- Resistance Level
- EPSM N/A
- AVTE $2.56
- Average True Range (ATR)
- EPSM 0.00
- AVTE 0.08
- MACD
- EPSM 0.00
- AVTE 0.00
- Stochastic Oscillator
- EPSM 0.00
- AVTE 80.00
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.